NUVALENT INC CLASS A (NUVL)
NASDAQ • Healthcare
Last close at July 21, 2026 at 20:00 UTC
Fundamentals Charts
About NUVALENT INC CLASS A
Nuvalent, Inc. develops targeted cancer therapies as a clinical-stage Biotechnology company listed on the NASDAQ as NUVL. The company centers its pipeline on kinase inhibitors for genetically defined tumors, and, in qualitative terms, it remains an early-stage drug developer rather than a commercial oncology company.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
NUVALENT INC CLASS A's Technical Indicators Summary
NUVL at 123.96 exhibits a strong buy structure with ADX signaling a firm trend and moving averages stacked bullishly, placing price well above the 200‑day. Momentum measures are robust—RSI is elevated and MACD is positive—while on‑balance volume is strongly supportive, indicating participation behind the advance. Volatility is muted per ATR, suggesting steady gains rather than erratic moves, although very high stochastic and money‑flow readings warn of short‑term overbought conditions. Technical takeaway: strong buy driven by clear trend strength, broad MA alignment, and confirming volume despite near‑term overbought signals.
| Indicator | Value |
|---|---|
RSI (14) | 67.59 |
Stochastic %K (14, 3, 3) | 94.39 |
CCI (20) | 82.74 |
WPR (14) | -6.12 |
Momentum (10) | 0.19 |
MFI | 88.54 |
MACD Level (12, 26) | 2.51 |
Bollinger Bands | $123.37 - $124.14 |
ATR (14) | $0.94 (0.76%) |
ADX (14) | 35.72 |
OBV | 66,730,660 |
Classic Pivot Point | $123.96 |
Fibonacci Pivot Point | $123.96 |
Simple Moving Averages | $104.24 - $123.92(5 indicators) |
Exponential Moving Averages | $103.61 - $123.82(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
With no meaningful move, NUVL holds level with the prior close. Sector performance is neutral (0.25%), offering little directional push for NUVL. A mild VIX change (-3.27%) reflects a small shift in volatility expectations.
Trading Volume
0
vs S&P 500 Today
Moderate Underperformance
-0.25%
52-Week Position
Near highs
99.9%
Updated: August 12, 2026 at 16:34 UTC